BiotechTube
BALT

BALT

Montmorency, France· Est.
baltgroup.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Balt is a global, private leader in the neurovascular medical device sector with over 45 years of history. It boasts the world's broadest portfolio of devices for stroke treatment and is leveraging its core expertise to enter the peripheral vascular market. The company has experienced significant growth since 2015, now employing over 1,000 people across 16 global sites. Its mission centers on close collaboration with physicians to develop clinically relevant solutions for high unmet medical needs.

NeurovascularStrokePeripheral Vascular

Technology Platform

Comprehensive platform for minimally invasive neurovascular and peripheral vascular interventions, including embolization coils, flow diverters, stents, thrombectomy devices, and access systems.

Opportunities

Expansion into the larger peripheral vascular embolization market represents a major growth vector, leveraging core neurovascular expertise.
The global stroke market continues to grow, driven by aging populations and adoption of minimally invasive procedures, supporting the core business.
The company's broadest-in-world neurovascular portfolio creates cross-selling opportunities and strengthens its value proposition to physicians.

Risk Factors

Intense competition from large, well-capitalized medical device conglomerates in both neuro and peripheral vascular markets.
Execution risk associated with entering and gaining share in the new peripheral vascular segment.
Dependence on favorable regulatory approvals and reimbursement policies across multiple global markets.

Competitive Landscape

In neurovascular, Balt competes directly with giants like Medtronic, Stryker, Johnson & Johnson, and Terumo. Its differentiation lies in a focused, broad portfolio and a physician-collaborative model. In peripheral embolization, it will face established players like Boston Scientific, Merit Medical, and Cook Medical, requiring it to prove clinical and economic value to a new customer base.

More companies in Drug Delivery & Formulation →More companies in France →